Suzuki N, Withers H R
J Natl Cancer Inst. 1978 Jan;60(1):179-83. doi: 10.1093/jnci/60.1.179.
The technique for the isolation of mutants was applied to establish highly clonogenic cells from a fibrosarcoma (FSA) that had an extremely poor growth capacity in vitro (10(-6)--10(-7) of surviving fraction of cells). After consecutive clonings, the surviving fraction of cells increased to 1--5 X 10(-1), whereas that of the ordinarily maintained culture remained at a low level. Selected clones were analyzed in vitro and/or in vivo. The results indicated that the FSA was composed of heterogeneous cells or cells having a potential variability in cloning ability in vitro, metastatic ability in vivo [lung colony-forming efficiency (LCFE)], and DNA content. The relatively high DNA content of one of the clones, FSA 1233, continued after growth in vivo or in vitro, indicating its hereditary nature. FSA 1233 was also demonstrated to have a lower LCFE when the cell suspension was made from a tumor rather than from a culture in vitro. The difference of surviving fractions between the cells in the two conditions was not enough to explain the difference in LCFE's between them. These cells could grow under either in vitro or in vivo conditions and could be made readily into single-cell suspensions. The cells are, therefore, available as a system for analysis of the response of cells in vitro after in vivo treatment with various agents.
采用分离突变体的技术,从一种体外生长能力极差(细胞存活分数为10^(-6)-10^(-7))的纤维肉瘤(FSA)中建立高克隆形成细胞。经过连续克隆后,细胞存活分数增加到1-5×10^(-1),而普通培养的细胞存活分数则维持在较低水平。对所选克隆进行体外和/或体内分析。结果表明,FSA由异质性细胞或在体外克隆能力、体内转移能力[肺集落形成效率(LCFE)]和DNA含量方面具有潜在变异性的细胞组成。其中一个克隆FSA 1233的相对高DNA含量在体内或体外生长后持续存在,表明其遗传性。当细胞悬液由肿瘤而非体外培养物制成时,FSA 1233也被证明具有较低的LCFE。两种条件下细胞的存活分数差异不足以解释它们之间LCFE的差异。这些细胞可以在体外或体内条件下生长,并且可以很容易地制成单细胞悬液。因此,这些细胞可作为一种系统,用于分析体内用各种试剂处理后细胞在体外的反应。